Pattern recognition in clinical chemistry: Tumor markers
β Scribed by S. Lanteri; P. Conti; A. Berbellini; G. Centioni; A. Polzonetti; R. Marassi; S. Zamponi
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 354 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0886-9383
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Current treatment protocols for Wilms tumor achieve 90% cure rates, but relapse risk and side effects from therapy remain challenging. Over the last decade, numerous markers have been proposed for classification and/or prediction of outcome. However, cohort sizes were quite variable and
## Abstract TRAβ1β60 antigen has been related to the presence of embryonal germ cell carcinoma (EC) and carcinoma __in situ__. Our study further investigated the clinical efficacy of TRAβ1β60 as a serum tumor marker for germ cell cancer in the testis. Three groups of patients with germ cell tumors
## Background: Telomerase is a ribonucleoprotein enzyme associated with cellular immortality that may be useful in determining the biologic potential of a tumor. neuroblastoma (nb), ganglioneuroblastoma (gnb), and ganglioneuroma (gn) are neuroblastic tumors (nts) that exhibit a spectrum of histolog
## Abstract ## Background. Hypoxia and tumor cell proliferation are important factors determining the treatment response of squamous cell carcinomas of the head and neck. Successful approaches have been developed to counteract these resistance mechanisms although usually at the cost of increased s